ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 431,83
-0,34%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV

  6. Biosyent Inc (RX) Cours

Biosyent Inc

Biosyent Inc (RX)

TSXV
11,74
0,10
(0,86%)
Fermé 21 Décembre 10:00PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
11,74
Prix Achat
11,74
Prix Vente
11,76
Volume échangé
2 953
11,62 Fourchette du Jour 11,84
0,00 Plage de 52 semaines 0,00
Cap du marché
140,34M
Clôture Veille
11,64
Ouverture
11,62
Dernière Transaction
100
@
11.74
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
11 954 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
21,72
Bénéfice par action (BPA)
0,54
Chiffre d'affairess
31,59M
Bénéfice net
6,46M

À propos de Biosyent Inc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.biosyent.com
Siège social
Mississauga, Ontario, Can
Fondé
-
Biosyent Inc est coté dans le secteur Pharmaceutical Preparations de la TSX Venture Exchange avec le ticker RX. Le dernier cours de clôture d'Biosyent était de $11,64. Au cours de la dernière année, les actions de Biosyent ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Biosyent compte actuellement 11 954 000 actions en circulation. La capitalisation boursière d'Biosyent est de $139,14 million. Biosyent a un ratio cours/bénéfice (ratio PE) de 21.72.

RX Dernières nouvelles

Plus de nouvelles

BioSyent Announces Renewal of Normal Course Issuer Bid

MISSISSAUGA, Ontario, Dec. 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has...

16 Décembre 2024
GlobeNewswire Inc.

FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc.

TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- This press release is being disseminated as required by National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider...

25 Novembre 2024
GlobeNewswire Inc.

BioSyent Releases Financial Results for Q3 and YTD 2024

MISSISSAUGA, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended...

20 Novembre 2024
GlobeNewswire Inc.

BioSyent Declares Fourth Quarter 2024 Dividend

MISSISSAUGA, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly...

20 Novembre 2024
GlobeNewswire Inc.

BioSyent Schedules Q3 and YTD 2024 Earnings Release for November 20, 2024

MISSISSAUGA, Ontario, Nov. 13, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...

13 Novembre 2024
GlobeNewswire Inc.

BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets

MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc...

20 Septembre 2024
GlobeNewswire Inc.

BioSyent Releases Financial Results for Q2 and H1 2024

MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q2) and six months (H1) ended June...

26 Août 2024
GlobeNewswire Inc.

BioSyent Declares Third Quarter 2024 Dividend

MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly...

26 Août 2024
GlobeNewswire Inc.

FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc.

TORONTO, July 24, 2024 (GLOBE NEWSWIRE) -- This press release is being disseminated as required by National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider...

25 Juillet 2024
GlobeNewswire Inc.

BioSyent In-Licenses Endocrinology Product for Canada

MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc...

12 Juin 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

RX - Frequently Asked Questions (FAQ)

What is the current Biosyent share price?
The current share price of Biosyent is $ 11,74
How many Biosyent shares are in issue?
Biosyent has 11 954 000 shares in issue
What is the market cap of Biosyent?
The market capitalisation of Biosyent is CAD 139,14M
What is the 1 year trading range for Biosyent share price?
Biosyent has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Biosyent?
The price to earnings ratio of Biosyent is 21,72
What is the cash to sales ratio of Biosyent?
The cash to sales ratio of Biosyent is 4,44
What is the reporting currency for Biosyent?
Biosyent reports financial results in CAD
What is the latest annual turnover for Biosyent?
The latest annual turnover of Biosyent is CAD 31,59M
What is the latest annual profit for Biosyent?
The latest annual profit of Biosyent is CAD 6,46M
What is the registered address of Biosyent?
The registered address for Biosyent is 2476 ARGENTIA ROAD, SUITE 402, MISSISSAUGA, ONTARIO, L5N 6M1
What is the Biosyent website address?
The website address for Biosyent is www.biosyent.com
Which industry sector does Biosyent operate in?
Biosyent operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GNFIGenifi Inc
$ 0,015
(200,00%)
4k
GHR.HGolden Harp Resources Inc
$ 0,10
(185,71%)
2,73k
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
2k
NICKNickelex Resource Corporation
$ 0,01
(100,00%)
1,1k
GAR.HGreen Arrow Resources Inc
$ 0,045
(80,00%)
1 000
CBAChampion Bear Resources Ltd
$ 0,015
(-62,50%)
101k
NIKL.HGK Resources LTD
$ 0,045
(-50,00%)
1 000
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
3,34M
WWTWater Ways Technologies Inc
$ 0,005
(-50,00%)
106,09k
COOOstrom Climate Solutions Inc
$ 0,05
(-50,00%)
109,5k
QNCQuantum Emotion Corp
$ 0,435
(26,09%)
7,32M
GXUGoviEx Uranium Inc
$ 0,055
(10,00%)
4,68M
FUUF3 Uranium Corp
$ 0,25
(6,38%)
3,64M
AUUAALUULA Composites Inc
$ 0,05
(0,00%)
3,63M
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
3,34M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSXV
RX
Biosyent
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés